Key Development CSL has announced that it will begin clinical studies to support regulatory approval of Horizon 2, its proprietary... Read more
Tag: #Global Trends
GSK’S US$2.52 BILLION RESTRUCTURING SIGNALS THAT BIG PHARMA IS SHIFTING FROM COST CUTTING TO PIPELINE ACCELERATION
Key Development GSK reported stronger-than-expected second quarter earnings while unveiling a US$2.52 billion restructuring programme designed to generate £1.9 billion... Read more
CAGRISEMA LAWSUIT PUTS NOVO NORDISK’S CLINICAL TRANSPARENCY AND INVESTOR TRUST UNDER NEW SCRUTINY
Key Development A US federal judge has allowed part of a shareholder lawsuit against Novo Nordisk to proceed. The surviving... Read more
ENVIRONMENTAL HEALTH RISKS ARE REDEFINING ESG ACCOUNTABILITY IN THE GLOBAL ENERGY SECTOR
Key Development Environmental health has become an increasingly important issue for industries operating in resource-rich regions. Recent allegations linking oil... Read more
MEDICAID FUNDING UNCERTAINTY IS RESHAPING THE FINANCIAL OUTLOOK FOR U.S. HOSPITAL OPERATORS
Key Development Universal Health Services (UHS) has revised its 2026 earnings outlook downward, citing growing uncertainty over the future of... Read more
PHILIP MORRIS’ US$1.2 BILLION U.S. EXPANSION REFLECTS THE ACCELERATING SHIFT TOWARD SMOKE-FREE NICOTINE PRODUCTS
Key Development Philip Morris International (PMI) has doubled its planned investment in its Aurora, Colorado manufacturing campus to approximately US$1.2... Read more
FDA SCRUTINY OF CAPRICOR’S CELL THERAPY UNDERSCORES A NEW BENCHMARK FOR RARE DISEASE INNOVATION
Key Development Capricor Therapeutics is facing a critical regulatory hurdle as U.S. FDA reviewers question whether the clinical evidence supporting... Read more
ASTRAZENECA’S EVOLVING DRUG PRICING STRATEGY SIGNALS A NEW ERA OF GLOBAL PHARMACEUTICAL MARKET NEGOTIATIONS
Key Development AstraZeneca says it is adjusting its pricing strategy for future medicines as the pharmaceutical industry responds to the... Read more
BOSTON SCIENTIFIC’S RESTRUCTURING PLAN REFLECTS A NEW PHASE OF OPERATIONAL DISCIPLINE IN THE MEDTECH INDUSTRY
Key Development Boston Scientific has approved a new company-wide restructuring programme designed to streamline operations, improve cost efficiency, and support... Read more









